Holen Sie sich die Stockscreener-App
501.29
2.30%
-11.79
Handel nachbörslich:
500.00
-1.29
-0.26%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$513.08
Offen:
$511
24-Stunden-Volumen:
3.09M
Relative Volume:
2.52
Marktkapitalisierung:
$192.46B
Einnahmen:
$42.37B
Nettoeinkommen (Verlust:
$6.14B
KGV:
32.85
EPS:
15.26
Netto-Cashflow:
$7.78B
1W Leistung:
-8.34%
1M Leistung:
-16.69%
6M Leistung:
-15.79%
1J Leistung:
+7.48%
1-Tages-Spanne:
$498.61
$512.77
1-Wochen-Bereich:
$498.61
$550.16
52-Wochen-Spanne:
$465.90
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Vergleichen Sie TMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| TMO | 501.29 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 230.06 | 166.23B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.92 | 36.47B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 191.04 | 34.67B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 419.83 | 34.38B | 3.84B | 866.24M | 792.60M | 9.80 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Protein Engineering Market Projected to Reach USD 7.39 Billion by 2032 with a CAGR of 14.72% - GlobeNewswire Inc.
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by First Western Trust Bank - MarketBeat
Investidor Profissional Gestao de Recursos Ltda. Has $720,000 Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment? - Yahoo Finance
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by Swiss National Bank - MarketBeat
Atlanta Consulting Group Advisors LLC Makes New $662,000 Investment in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Mill Creek Capital Advisors LLC - MarketBeat
Stock Repurchase Plan Announced by Thermo Fisher Scientific (NYSE:TMO) Board of Directors - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Bought by Natixis Advisors LLC - MarketBeat
Mizuho Securities USA LLC Boosts Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Kentucky Retirement Systems Insurance Trust Fund Sells 1,002 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Kentucky Retirement Systems Sells 2,153 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific plans new Pease hangar and office: Here are details - Seacoastonline.com
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market - MarketWatch
Thermo Fisher's $4 Billion Buyback: A Game-Changer for Investors - GuruFocus.com
Thermo Fisher eliminating 160 jobs, closing Massachusetts facility - MedTech Dive
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Bought by Simplify Asset Management Inc. - MarketBeat
Pharmaceutical Sterility Testing Market to Drive Revenue to USD 3.79 Billion by 2032 | CAGR 11.58% - GlobeNewswire Inc.
Chromatography Systems Market Industry Detailed Exploration, - openPR
CIBC Asset Management Inc Purchases 6,313 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Board Approves New $4 Billion Stock Buyback - Marketscreener.com
Thermo Fisher Scientific Launches Massive $4B Share Buyback Program | TMO Stock News - StockTitan
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases - The Bakersfield Californian
DNA Synthesis Market Analysis and Forecast, 2024-2028 - GlobeNewswire Inc.
Curi RMB Capital LLC Boosts Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Zacks Research Brokers Decrease Earnings Estimates for TMO - MarketBeat
Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch
ING Groep NV Sells 114,777 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher to develop colorectal cancer screening test - SCNow
Ferguson Wellman Capital Management Inc. Trims Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Huntington National Bank Raises Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
KBC Group NV Boosts Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific's (NYSE:TMO) five-year total shareholder returns outpace the underlying earnings growth - Yahoo Finance
Protein Trends Technologies Market May See a Big Move | Thermo Fisher Scientific, Formulatrix, Bruker - openPR
Thermo Fisher Scientific: Near The Bottom And Attractively Valued - Seeking Alpha
Layoff Tracker: Sensei to Cut 46% of Workforce, Close Research Site - BioSpace
Biochips Market Is Booming Worldwide 2024-2031 | Illumina, - openPR
Fungal Keratitis Treatment Market Will Accelerate Rapidly with - openPR
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by Oppenheimer Asset Management Inc. - MarketBeat
Oppenheimer & Co. Inc. Sells 1,168 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific and Mainz Biomed Partner to Advance Colorectal Cancer Screening Technology - Citybuzz
Simmons Bank Grows Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening - Nasdaq
Bancreek Capital Management LP Raises Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Victory Capital Management Inc. Trims Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Prime Capital Investment Advisors LLC Trims Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
PCR Systems Market Growth, Industry Development and Forecast - openPR
The Art of Valuation: Discovering Thermo Fisher Scientific Inc's Intrinsic Value - GuruFocus.com
Lentiviral Vectors Market Overall Study Report 2024-2031 | - openPR
Thermo Fisher Scientific Inc. (NYSE:TMO) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):